{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:10:29Z","timestamp":1788207029819,"version":"build-2803163510"},"reference-count":108,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejase.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Echocardiography"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.echo.2018.01.016","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T17:50:12Z","timestamp":1522345812000},"page":"639-649.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Echocardiographic Assessment of Patients with Fabry Disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Darwin F.","family":"Yeung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Sirrs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Y.C.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6331-7003","authenticated-orcid":false,"given":"Kenneth","family":"Gin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Jue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvathy","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa S.M.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.echo.2018.01.016_bib1","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry\u2019s disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.echo.2018.01.016_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.echo.2018.01.016_bib3","first-page":"1004","article-title":"Fabry disease\u2014a diagnostic and therapeutic challenge","volume":"125","author":"Houge","year":"2005","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/j.echo.2018.01.016_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13023-015-0253-6","article-title":"Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document","volume":"10","author":"Biegstraaten","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.echo.2018.01.016_bib5","first-page":"9","article-title":"Third in a series on Fabry disease: what is the importance of imaging in Fabry disease?","volume":"14","author":"Jurcut","year":"2016","journal-title":"E-J Cardiol Pract"},{"key":"10.1016\/j.echo.2018.01.016_bib6","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.4081\/cardiogenetics.2013.e3","article-title":"Echocardiography in Fabry disease","volume":"3","author":"Niemann","year":"2013","journal-title":"Cardiogenetics"},{"key":"10.1016\/j.echo.2018.01.016_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/01.hco.0000131534.25034.43","article-title":"Tissue Doppler imaging in Fabry disease","volume":"19","author":"Pieroni","year":"2004","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.echo.2011.07.012","article-title":"Echocardiographic assessment of Fabry cardiomyopathy: early diagnosis and follow-up","volume":"24","author":"Pieroni","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2018.01.016_bib9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.0954-6820.1947.tb06596.x","article-title":"Angiokeratoma corporis diffusum (universale) Fabry, as a sign of an unknown internal disease; two autopsy reports","volume":"128","author":"Pompen","year":"1947","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.echo.2018.01.016_bib10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0002-9343(59)90200-1","article-title":"Fabry\u2019s disease (angiokeratoma corporis diffusum universale). An unusual syndrome with multisystem involvement and unique skin manifestations","volume":"27","author":"Karr","year":"1959","journal-title":"Am J Med"},{"key":"10.1016\/j.echo.2018.01.016_bib11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0002-8703(80)90060-5","article-title":"The M-mode echocardiogram in Fabry\u2019s disease","volume":"100","author":"Bass","year":"1980","journal-title":"Am Heart J"},{"key":"10.1016\/j.echo.2018.01.016_bib12","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1067\/mhj.2000.105105","article-title":"New insights in cardiac structural changes in patients with Fabry\u2019s disease","volume":"139","author":"Linhart","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.echo.2018.01.016_bib13","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/eurheartj\/ehp588","article-title":"Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activity","volume":"31","author":"Wu","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.echo.2018.01.016_bib14","first-page":"705","article-title":"Four cases of Fabry\u2019s disease mimicking hypertrophic cardiomyopathy","volume":"18","author":"Tanaka","year":"1988","journal-title":"J Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF01606034","article-title":"Cardiocyte storage and hypertrophy as a sole manifestation of Fabry\u2019s disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy","volume":"417","author":"Elleder","year":"1990","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.echo.2018.01.016_bib16","first-page":"469","article-title":"Cardiac variant of Fabry\u2019s disease mimicking hypertrophic cardiomyopathy","volume":"44","author":"Chimenti","year":"1999","journal-title":"Cardiologia"},{"key":"10.1016\/j.echo.2018.01.016_bib17","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","article-title":"Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy","volume":"105","author":"Sachdev","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2018.01.016_bib18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.hlc.2004.01.030","article-title":"A case of Fabry disease mimicking hypertrophic cardiomyopathy","volume":"13","author":"Thomas","year":"2004","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.echo.2018.01.016_bib19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/echo.12900","article-title":"Apical left ventricular hypertrophy and mid-ventricular obstruction in Fabry disease","volume":"32","author":"Cianciulli","year":"2015","journal-title":"Echocardiography"},{"key":"10.1016\/j.echo.2018.01.016_bib20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijcard.2015.10.140","article-title":"Late gadolinium enhancement image masquerading as hypertrophic cardiomyopathy in Fabry disease receiving enzyme replacement therapy","volume":"203","author":"Yano","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry\u2019s disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.echo.2018.01.016_bib22","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2009.12.040","article-title":"Infiltrative cardiovascular diseases: cardiomyopathies that look alike","volume":"55","author":"Seward","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.hlc.2007.03.007","article-title":"Cardiovascular manifestations in Fabry disease: a clinical and echocardiographic study","volume":"16","author":"Sadick","year":"2007","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.echo.2018.01.016_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1442-200X.1988.tb02495.x","article-title":"Cardiovascular manifestations in Fabry\u2019s disease\u2014age-related changes in hemizygotes and heterozygotes","volume":"30","author":"Yanagawa","year":"1988","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.echo.2018.01.016_bib25","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","article-title":"Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey","volume":"28","author":"Linhart","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.echo.2018.01.016_bib26","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0735-1097(86)80238-8","article-title":"Echocardiographic abnormalities and disease severity in Fabry\u2019s disease","volume":"7","author":"Goldman","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijcard.2008.03.007","article-title":"Onset and progression of the Anderson-Fabry disease related cardiomyopathy","volume":"130","author":"Kampmann","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib28","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jacc.2010.11.018","article-title":"Cardiovascular events in patients with Fabry disease natural history data from the Fabry registry","volume":"57","author":"Patel","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/ehjci\/jet197","article-title":"Left ventricular apical aneurysm: a novel phenotype of Fabry\u2019s disease","volume":"15","author":"Agarwal","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2018.01.016_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.12998\/wjcc.v3.i6.519","article-title":"Advanced Anderson-Fabry disease presenting with left ventricular apical aneurysm and ventricular tachycardia","volume":"3","author":"Poulin","year":"2015","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.echo.2018.01.016_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000330924","article-title":"Left ventricular noncompaction in a patient with Fabry disease: overdiagnosis, morphological manifestation of Fabry disease or two unrelated rare conditions in the same patient?","volume":"119","author":"Azevedo","year":"2011","journal-title":"Cardiology"},{"key":"10.1016\/j.echo.2018.01.016_bib32","doi-asserted-by":"crossref","first-page":"565.e1","DOI":"10.1016\/j.repc.2014.02.021","article-title":"Histopathological evidence of Fabry disease in a female patient with left ventricular noncompaction","volume":"33","author":"Martins","year":"2014","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib33","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.jacc.2005.11.070","article-title":"Fabry\u2019s disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization","volume":"47","author":"Pieroni","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib34","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.jacc.2008.02.046","article-title":"The binary endocardial appearance is a poor discriminator of Anderson-Fabry disease from familial hypertrophic cardiomyopathy","volume":"51","author":"Kounas","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/ejechocard\/jen129","article-title":"Anderson-Fabry disease: long-term echocardiographic follow-up under enzyme replacement therapy","volume":"9","author":"Kovacevic-Preradovic","year":"2008","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.echo.2018.01.016_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1475-097X.2008.00851.x","article-title":"Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance","volume":"29","author":"Koskenvuo","year":"2009","journal-title":"Clin Physiol Funct Imaging"},{"key":"10.1016\/j.echo.2018.01.016_bib37","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/ejechocard\/jer112","article-title":"The endocardial binary appearance (\u201cbinary sign\u201d) is an unreliable marker for echocardiographic detection of Fabry disease in patients with left ventricular hypertrophy","volume":"12","author":"Mundigler","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.echo.2018.01.016_bib38","first-page":"831","article-title":"Nomen est omen. Fabry disease","volume":"9","author":"Weidemann","year":"2008","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.echo.2018.01.016_bib39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijcard.2005.08.023","article-title":"Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy","volume":"111","author":"Hoigne","year":"2006","journal-title":"Int J Cardiol"},{"issue":"suppl 2","key":"10.1016\/j.echo.2018.01.016_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1012428009627","article-title":"Cardiac manifestations in Fabry disease","volume":"24","author":"Linhart","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.echo.2018.01.016_bib41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00392-005-0284-4","article-title":"Morbus Fabry of the heart. Why should cardiologists care?","volume":"94","author":"Strotmann","year":"2005","journal-title":"Z Kardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ultrasmedbio.2010.10.017","article-title":"Prominent papillary muscles in Fabry disease: a diagnostic marker?","volume":"37","author":"Niemann","year":"2011","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.echo.2018.01.016_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0002-8703(95)90062-4","article-title":"Inherited restrictive cardiomyopathy in a 74-year-old woman: a case of Fabry\u2019s disease","volume":"129","author":"Hillsley","year":"1995","journal-title":"Am Heart J"},{"key":"10.1016\/j.echo.2018.01.016_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/08035320510028049","article-title":"The right ventricle in Fabry disease","volume":"94","author":"Kampmann","year":"2005","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.echo.2018.01.016_bib45","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.echo.2008.09.002","article-title":"Right ventricular involvement in Fabry disease","volume":"21","author":"Palecek","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2018.01.016_bib46","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1136\/hrt.2010.204586","article-title":"The right ventricle in Fabry disease: natural history and impact of enzyme replacement therapy","volume":"96","author":"Niemann","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.echo.2018.01.016_bib47","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.echo.2016.11.014","article-title":"Right ventricular hypertrophy, systolic function, and disease severity in Anderson-Fabry disease: an echocardiographic study","volume":"30","author":"Graziani","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2018.01.016_bib48","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/eurheartj\/ehi143","article-title":"The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease","volume":"26","author":"Weidemann","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.echo.2018.01.016_bib49","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10554-014-0551-4","article-title":"Global cardiac alterations detected by speckle-tracking echocardiography in Fabry disease: left ventricular, right ventricular, and left atrial dysfunction are common and linked to worse symptomatic status","volume":"31","author":"Morris","year":"2015","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2018.01.016_bib50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0002-9149(69)90055-1","article-title":"The heart in Fabry\u2019s disease. A histochemical and electron microscopic study","volume":"24","author":"Ferrans","year":"1969","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib51","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0002-9149(75)90468-3","article-title":"Cardiac manifestations of Fabry\u2019s disease. Report of a case with mitral insufficiency and electrocardiographic evidence of myocardial infarction","volume":"36","author":"Becker","year":"1975","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib52","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.CIR.54.5.818","article-title":"Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies","volume":"54","author":"Desnick","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2018.01.016_bib53","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","article-title":"An atypical variant of Fabry\u2019s disease with manifestations confined to the myocardium","volume":"324","author":"von Scheidt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.echo.2018.01.016_bib54","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.athoracsur.2008.06.023","article-title":"Fabry disease with aortic regurgitation","volume":"87","author":"Choi","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.echo.2018.01.016_bib55","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1034\/j.1399-0004.2003.630107.x","article-title":"Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patients","volume":"63","author":"Senechal","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/j.echo.2018.01.016_bib56","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/eurheartj\/eht098","article-title":"Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease","volume":"34","author":"Kramer","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.echo.2018.01.016_bib57","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1161\/01.CIR.0000061952.27445.A0","article-title":"Early detection of Fabry cardiomyopathy by tissue Doppler imaging","volume":"107","author":"Pieroni","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2018.01.016_bib58","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.echo.2013.08.024","article-title":"Left atrial enlargement and reduced atrial compliance occurs early in Fabry cardiomyopathy","volume":"26","author":"Boyd","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2018.01.016_bib59","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.echo.2016.10.014","article-title":"Impaired left atrial function in Fabry disease: a longitudinal speckle-tracking echocardiography study","volume":"30","author":"Pichette","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2018.01.016_bib60","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1399-0004.1986.tb01255.x","article-title":"Cardiovascular manifestations in Fabry\u2019s disease. A high incidence of mitral valve prolapse in hemizygotes and heterozygotes","volume":"29","author":"Sakuraba","year":"1986","journal-title":"Clin Genet"},{"key":"10.1016\/j.echo.2018.01.016_bib61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1399-0004.1991.tb03018.x","article-title":"Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A","volume":"39","author":"Nagao","year":"1991","journal-title":"Clin Genet"},{"key":"10.1016\/j.echo.2018.01.016_bib62","first-page":"306","article-title":"Fabry disease in a female patient due to a de novo point mutation at position 691 of exon 5","volume":"11","author":"Brokalaki","year":"2006","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.echo.2018.01.016_bib63","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1445-5994.2002.00291.x","article-title":"Clinical features of Fabry\u2019s disease in Australian patients","volume":"32","author":"Galanos","year":"2002","journal-title":"Intern Med J"},{"key":"10.1016\/j.echo.2018.01.016_bib64","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ultrasmedbio.2008.10.010","article-title":"Heart valve involvement in Fabry cardiomyopathy","volume":"35","author":"Weidemann","year":"2009","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.echo.2018.01.016_bib65","first-page":"589","article-title":"Echocardiographic findings in a case of Fabry\u2019s disease with aortic regurgitation and complete AV block, and in his family members","volume":"18","author":"Iwase","year":"1988","journal-title":"J Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1620\/tjem.217.169","article-title":"Decline of plasma brain natriuretic peptide during enzyme replacement therapy in a female patient with heterozygous Fabry\u2019s disease","volume":"217","author":"Masugata","year":"2009","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.echo.2018.01.016_bib67","first-page":"485","article-title":"Delayed diagnosis of Fabry disease presenting as myocardial ischaemia","volume":"53","author":"Marci","year":"2012","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib68","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1540-8191.2012.01459.x","article-title":"Cardiac surgery in patients with Fabry\u2019s disease: review of literature","volume":"27","author":"Fernandez","year":"2012","journal-title":"J Card Surg"},{"key":"10.1016\/j.echo.2018.01.016_bib69","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/eurheartj\/ehp426","article-title":"Aortic remodelling in Fabry disease","volume":"31","author":"Barbey","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.echo.2018.01.016_bib70","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/hrt.2004.035584","article-title":"The natural history of left ventricular systolic function in Anderson-Fabry disease","volume":"91","author":"Shah","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.echo.2018.01.016_bib71","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1161\/01.CIR.98.14.1457","article-title":"Restrictive cardiomyopathy secondary to Fabry\u2019s disease","volume":"98","author":"Cantor","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2018.01.016_bib72","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1399-0004.2004.00284.x","article-title":"Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry\u2019s disease","volume":"66","author":"Spinelli","year":"2004","journal-title":"Clin Genet"},{"key":"10.1016\/j.echo.2018.01.016_bib73","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.echo.2011.05.021","article-title":"Tei index in Fabry disease","volume":"24","author":"Niemann","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2018.01.016_bib74","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.amjcard.2006.07.088","article-title":"Significance of asymmetric basal posterior wall thinning in patients with cardiac Fabry\u2019s disease","volume":"99","author":"Kawano","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib75","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/01.CIR.104.2.128","article-title":"Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy","volume":"104","author":"Nagueh","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2018.01.016_bib76","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1161\/01.CIR.0000019070.70491.6D","article-title":"Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy","volume":"105","author":"Ho","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2018.01.016_bib77","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/01.CIR.102.10.1158","article-title":"Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function","volume":"102","author":"Urheim","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2018.01.016_bib78","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.CIR.0000091253.71282.04","article-title":"Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study","volume":"108","author":"Weidemann","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2018.01.016_bib79","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.CIR.0000139847.74101.03","article-title":"Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy","volume":"110","author":"Chimenti","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2018.01.016_bib80","first-page":"613","article-title":"Detection of preclinical left ventricular dysfunction in Fabry disease: the contribution of tissue Doppler","volume":"25","author":"Fiuza","year":"2006","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib81","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00380-005-0852-6","article-title":"Early diastolic mitral annular velocity and color M-mode flow propagation velocity in the evaluation of left ventricular diastolic function in patients with Fabry disease","volume":"21","author":"Palecek","year":"2006","journal-title":"Heart Vessels"},{"key":"10.1016\/j.echo.2018.01.016_bib82","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijcard.2008.04.075","article-title":"Clinical usefulness of tissue Doppler imaging in predicting preclinical Fabry cardiomyopathy","volume":"132","author":"Toro","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib83","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcmg.2011.01.020","article-title":"Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment","volume":"4","author":"Niemann","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2018.01.016_bib84","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","article-title":"Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium","volume":"24","author":"Moon","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.echo.2018.01.016_bib85","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJM200107053450104","article-title":"Improvement in cardiac function in the cardiac variant of Fabry\u2019s disease with galactose-infusion therapy","volume":"345","author":"Frustaci","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.echo.2018.01.016_bib86","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1023\/B:BOLI.0000005658.14563.77","article-title":"Enzyme replacement therapy in heterozygous females with Fabry disease: results of a phase IIIB study","volume":"26","author":"Baehner","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.echo.2018.01.016_bib87","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2362.2004.01424.x","article-title":"Fabry disease: overall effects of agalsidase alfa treatment","volume":"34","author":"Beck","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.echo.2018.01.016_bib88","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/hrt.2006.104026","article-title":"Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa","volume":"94","author":"Hughes","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.echo.2018.01.016_bib89","doi-asserted-by":"crossref","first-page":"W97","DOI":"10.2214\/AJR.08.1201","article-title":"Delayed-enhanced cardiac MRI for differentiation of Fabry\u2019s disease from symmetric hypertrophic cardiomyopathy","volume":"192","author":"De Cobelli","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.echo.2018.01.016_bib90","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/hrt.2008.162800","article-title":"Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study","volume":"95","author":"Imbriaco","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.echo.2018.01.016_bib91","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.clinthera.2009.09.008","article-title":"Effect of agalsidase alfa replacement therapy on Fabry disease-related hypertrophic cardiomyopathy: a 12- to 36-month, retrospective, blinded echocardiographic pooled analysis","volume":"31","author":"Kampmann","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.echo.2018.01.016_bib92","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/S0140-6736(09)61493-8","article-title":"Enzyme replacement therapy with agalsidase alfa in patients with Fabry\u2019s disease: an analysis of registry data","volume":"374","author":"Mehta","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.echo.2018.01.016_bib93","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","article-title":"Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: evidence for a better outcome with early treatment","volume":"119","author":"Weidemann","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2018.01.016_bib94","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.amjcard.2005.11.087","article-title":"Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry\u2019s cardiomyopathy","volume":"97","author":"Beer","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2018.01.016_bib95","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1093\/eurheartj\/ehm454","article-title":"A new echocardiographic approach for the detection of non-ischaemic fibrosis in hypertrophic myocardium","volume":"28","author":"Weidemann","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.echo.2018.01.016_bib96","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/hrt.2010.192641","article-title":"Quantification of myocardial iron deposition by two-dimensional speckle tracking in patients with beta-thalassaemia major and Blackfan-Diamond anaemia","volume":"97","author":"Garceau","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.echo.2018.01.016_bib97","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1540-8175.2012.01704.x","article-title":"Systolic myocardial mechanics in patients with Anderson-Fabry disease with and without left ventricular hypertrophy and in comparison to nonobstructive hypertrophic cardiomyopathy","volume":"29","author":"Gruner","year":"2012","journal-title":"Echocardiography"},{"key":"10.1016\/j.echo.2018.01.016_bib98","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/echo.13496","article-title":"Loss of base-to-apex circumferential strain gradient: a specific pattern of Fabry cardiomyopathy?","volume":"34","author":"Labombarda","year":"2017","journal-title":"Echocardiography"},{"key":"10.1016\/j.echo.2018.01.016_bib99","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/10976640600605002","article-title":"The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease","volume":"8","author":"Moon","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.echo.2018.01.016_bib100","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/echo.12216","article-title":"Two-dimensional speckle tracking echocardiography for early detection of myocardial damage in young patients with Fabry disease","volume":"30","author":"Saccheri","year":"2013","journal-title":"Echocardiography"},{"key":"10.1016\/j.echo.2018.01.016_bib101","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12968-016-0233-6","article-title":"Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease","volume":"18","author":"Deva","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.echo.2018.01.016_bib102","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.echo.2013.09.005","article-title":"Systolic and diastolic function assessment in Fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements","volume":"26","author":"Shanks","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2018.01.016_bib103","author":"Sirrs"},{"key":"10.1016\/j.echo.2018.01.016_bib104","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/ejechocard\/jer109","article-title":"Usefulness of tissue Doppler on early detection of cardiac disease in Fabry patients and potential role of enzyme replacement therapy (ERT) for avoiding progression of disease","volume":"12","author":"Zamorano","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.echo.2018.01.016_bib105","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.1371\/journal.pone.0000598","article-title":"Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg\/kg","volume":"2","author":"Vedder","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.echo.2018.01.016_bib106","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/14017431.2017.1332383","article-title":"Echocardiographic and clinical findings in patients with Fabry disease during long-term enzyme replacement therapy: a nationwide Danish cohort study","volume":"51","author":"Madsen","year":"2017","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.echo.2018.01.016_bib107","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","article-title":"Agalsidase-beta therapy for advanced Fabry disease: a randomized trial","volume":"146","author":"Banikazemi","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.echo.2018.01.016_bib108","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/joim.12077","article-title":"Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications","volume":"274","author":"Weidemann","year":"2013","journal-title":"J Intern Med"}],"container-title":["Journal of the American Society of Echocardiography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0894731718300415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0894731718300415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T05:03:39Z","timestamp":1760245419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0894731718300415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":108,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0894731718300415"],"URL":"https:\/\/doi.org\/10.1016\/j.echo.2018.01.016","relation":{},"ISSN":["0894-7317"],"issn-type":[{"value":"0894-7317","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Echocardiographic Assessment of Patients with Fabry Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Echocardiography","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.echo.2018.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"2018 by the American Society of Echocardiography.","name":"copyright","label":"Copyright"}]}}